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Two simple, sensitive, selective and inexpensive spectrophotometric methods are described for the 
determination of simvastatin (SMT) in bulk drug and in tablets using permanganate as the oxidimetric 
reagent. In method A, SMT is treated with a measured excess of permanganate in acetic acid medium and 
the unreacted oxidant is measured at 550 nm, whereas in method B the reaction is carried out in alkaline 
medium and the resulting manganate is measured at 610 nm. In method A, the amount of permanganate 
reacted corresponds to the SMT content and the absorbance is found to decrease linearly with the 
concentration; and in method B, the absorbance increases with concentration. The working conditions of 
assays were optimized, and the methods were validated according to the current ICH guidelines. Under 
optimum conditions, SMT could be assayed in the concentration ranges, 1.47 – 17.67x10-5 and 2.27 – 27.18 
x10-6 mol/L by method A and method B, respectively. The calculated molar absorptivities are 3.2 x 103 
and 2.5 x 104 L/mol/cm for method A and method B, respectively with corresponding Sandell sensitivity 
values of 0.0387 and 0.0178 µg/cm2. The limits of detection (LOD) and quantification (LOQ) have also 
been reported. Accuracy and precision for the assay were determined by calculating the intra-day and 
inter-day at three concentrations; the intra-day RSD was < 2% and the accuracy was better than 2.15 % 
(RE). The methods were applied successfully for the determination of SMT in tablet dosage form with a 
high percentage of recovery, good accuracy and precision, and without measurable interference by the 
excipients. The accuracy was further ascertained from placebo and synthetic mixture analysis and also 
from the spike-recovery method.
Uniterms: Simvastatin assay. Spectrophotometry. Permanganate. Pharmaceutical products.
Dois métodos espectrofotométricos simples, sensíveis, seletivos e baratos são descritos para a determinação 
de sinvastatina (SMT) a granel e em comprimidos, utilizando permanganato como reagente oxidimétrico. 
No método A, a SMT é tratada com excesso conhecido de permanganato em meio de ácido acético e o 
oxidante que não reage é medido a 550 nm, enquanto no método B, a reação é efetuada em meio alcalino 
e o manganato resultante é medido a 610 nm. No método A, a quantidade de permanganato que reage 
corresponde ao conteúdo de SMT e a absorbância diminui linearmente com o aumento da concentração; 
no método B, a absorbância  aumenta com o aumento da concentração. As condições de trabalho do 
ensaio foram otimizadas e os métodos, validados de acordo com as normas do ICH. Sob condições 
ótimas, a SMT pode ser ensaiada nas faixas de concentração de 1,47– 17,67x10-5 e de 2,27–27,18 x10-6 
mol/L pelo método A e B, respectivamente. As absortividades molares calculadas são 2 x 103 e 2,5 x 104 
L/ mol/cm,  respectivamente, para os métodos A e B, com os valores correspondentes de sensibilidade de 
Sandell de 0,0387 e 0,0178 µg/cm2. Os limites de detecção (LOQ) também foram relatados. A exatidão 
e a precisão do ensaio foram determinadas pelo cálculo de três concentrações intra- e inter-dia; a RSD 
intra-dia foi <2% e a exatidão foi melhor que 2,15% (RE). Os métodos foram aplicados com sucesso à 
determinação de SMT em comprimidos com alta porcentagem de recuperação, boa exatidão e precisão 
e sem interferência mensurável dos excipientes. A exatidão foi posteriormente determinada no placebo 
e na mistura sintética e, também, pelo método de spike recovery.
Unitermos: Sinvastatina/ensaio. Espectrofotometria. Permanganato. Produtos farmacêuticos.
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INTRODUCTION
Simvastatin (SMT), chemically known as (1S, 2S, 8S, 
8aR)-1,2,6,8,8a-hexahydro-1-(2-((2R, 4R)-tetrahyro-4- 
hydroxy-6-oxo-2H-pyran-2-yl)-2,6-dimethylnapthalen-8-
yl 2,2-dimethylbutanoate (Figure 1), belongs to the group 
of cholesterol-lowering lactones known as statins which, 
in 2007, were identified as being among the most widely 
prescribed drugs in the world. Statins lower cholesterol by 
inhibiting the synthesis of movalinic acid, which is the key 
precursor in cholesterol synthesis. SMT has been shown to 
be effective as an antilipemic agent. It is administered as a 
pro drug, and in the liver it is hydrolysed to the ß-hydroxy 
acid form (Mc Evoy, 2002). The drug is officially listed 
in the 2004 United States Pharmacopoeia and the official 
method of its determination is high-performance liquid 
chromatography (The United State Pharmacopoeia, 2002). 
Various other methods such as UV-spectrophotometry 
(Erk, 2002; Xu, 2001; Zhonghong, Shurong 2000; Wang, 
Asgharnejad, 2000; Arayne et al., 2007; Carlcucci, Ma-
zzeo, 1992), HPLC (Carlcucci, Mazzeo, 1992; Jianwei, 
Ying, 2005; Ali et al., 2006; Carolina et al., 2004, Xan et 
al., 2000; Wang, 2000), HPTLC (Chandhari et al., 2007), 
micellar electrokinetic chromatography (Srinivasu et al., 
2002) and voltammetry (Coruh, Ozkan, 2006) have been 
reported for the assaying of SMT in pharmaceuticals. There 
is only one report on the use of visible spectrophotometry 
which describes three methods (Saradhi et al. 2007) for 
SMT. One procedure is based on the reduction of iron 
(III) by SMT to iron (II) and subsequent formation of 
prussian blue with ferricyanide measurable at 730 nm. In 
the other two procedures, the iron (II) formed is chelated 
with 1,10-phenanthroline or 2,2’-bipyridine followed by 
measurement of absorbance at 480 or 490 nm. The present 
paper describes two visible spectrophotometric methods 
using KMnO
4
 as an oxidizing agent in both acid and basic 
medium. Simplicity, sensitivity wide linear ranges, mild 
experimental conditions and above all cost-effectiveness 
characterize the proposed methods. Further, the methods 
were found to possess adequate accuracy and precision.
EXPERIMENTAL
Apparatus
A Systronics model 106 digital spectrophotometric 
with 1-cm matched quartz cells was used for all absorban-
ce measurements.
Reagents and materials
All chemicals used were of analytical reagent gra-
de and distilled water was used to prepare all solutions. 
Potassium permanganate (1x10-2 mol/L) was prepared by 
dissolving about 0.395 g of the chemical (Merck, Mumbai, 
India) in water and diluting to 250 mL; and standardized 
using H.A Bright’s procedure (A.I. Vogel, 3rd edition, 
1961, p. 280). It was further diluted to 3.164 x 10-3 mol/L 
KMnO
4
 for method A and 6.328 x 10-3 mol/L KMnO
4
 for 
method B. Acetic acid (3:2) was prepared by diluting con-
centrated acetic acid (Merck, Mumbai, India, Sp. gr. 1.05) 
appropriately with water. Sodium hydroxide solution (0.3 
and 0.5 mol/L) was prepared by dissolving the chemical 
(Merck, Mumbai, India) in water. Pharmaceutical grade 
SMT, certified to be 99.88% pure, was kindly provided by 
Jubiliant Organosis, Nanjangud, India, as a gift and was 
used as received. A 2.944x10-3 mol/L SMT was prepared 
by dissolving 32.5 mg of SMT in 3:2 acetic acid and made 
up to 250 mL with the same acid used for method A. A 
9.059x10-5 mol/L SMT was prepared by dissolving 10 mg 
of SMT in 0.3 mol/L NaOH with the aid of heat and made 
up to 250 mL with 0.3 mol/L NaOH and used in method 
B. Tablets containing SMT such as Zosta (USV Ltd, India) 
and Simvas (Micro labs Ltd, India) were purchased from 
the local market.
METHODS
Method A
Different aliquots of standard solution (0.5-6.0 mL, 
2.944 x 10-4 mol/L ) of pure SMT were transferred into a 
series of 10 mL calibrated flasks by means of micro burette 
and the total volume was adjusted to 6.0 mL with 3:2 acetic 
acid. A volume of 1 mL of 3.164 x 10-3 mol/L KMnO
4
 was 
added to each flask accurately, and kept aside for 10 min 
with occasional swirling before diluting to the mark with 
water. The absorbance was recorded at 550 nm against a 
water blank.
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FIGURE 1 - Structure of simvastatin.
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Method B
Into a series of 10 mL calibrated flasks, 0.25-3.0 mL 
of 9.059 x 10-5 mol/L  pure SMT solution were buretted and 
the total volume was made up to 3.0 mL with 0.3 mol/L 
NaOH. To each flask was added 1 mL of 0.5 mol/L NaOH 
followed by 1 mL of 6.328 x 10-3 mol/L KMnO
4
 solution. 
The flasks were kept aside for 20 min with occasional 
shaking and the volume was made up to the mark with 
water. The absorbance was recorded at 610 nm against 
the reagent blank.
Assay procedure for tablets
Twenty tablets were accurately weighed and pow-
dered. A portion of tablet powder equivalent to 20 mg of 
SMT was accurately weighed into a 100 mL calibrated 
flasks, 40 mL of 3:2 acetic acid was added and shaken for 
20 min. Then, the volume was made up to the mark with 
the same acid, mixed well and filtered using a Whatman 
No. 42 filter paper. First, a 10 mL portion of the filtrate 
was rejected and a convenient aliquot (around 2 or 3 mL) 
was subjected to analysis by the procedure described under 
method A. Another portion of the tablet powder containing 
20 mg of SMT was accurately weighed and transferred to 
a separating funnel containing about 40 mL of water and 
mixed. The content was extracted with 5 x 5mL portions of 
chloroform, where the combined organic layer was dried 
over anhydrous sodium sulphate, and transferred into a 
dry beaker and evaporated to dryness in a water bath. The 
residue was dissolved in 0.3 mol/L NaOH with the aid 
of heat and transferred to a 100 mL volumetric flask and 
diluted to the mark with 0.3 mol/L NaOH. The solution 
was diluted to 9.059 x 10-5 mol/L SMT with the same alkali 
solution and the analysis was completed by following the 
procedure given under method B.
RESULTS AND DISCUSSION
The methods are based on the oxidation of SMT by 
KMnO
4
 in either acid or alkaline medium followed by 
measurement of the residual permanganate at 550 nm in 
method A or the reduced manganate at 610 nm in method 
B. The possible reaction scheme is given in Figure 2.
Optimization of experimental conditions
In method A, when a fixed concentration of perman-
ganate was reacted with increasing concentrations of SMT in 
acetic acid medium, there occurred a concomitant fall in the 
concentration of permanganate as revealed by the decreasing 
absorbance at 550 nm (Figure 3 and Figure 4), which served 
SMT + KMnO4
Oxidation product of SMT + Mn 2++ Unreacted  KMnO4
Oxidation product of SMT + MnO 42-
H
+ , M
etho
d A
OH -
, Method B
(Absorbance Measured at 550 nm)
(Bluish-green colour, measured at 610 nm)
FIGURE 2 - Tentative reaction scheme.
FIGURE 3 - Calibration curves for method A and method B.
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as the basis for quantification. A preliminary experiment 
showed that permanganate can be determined up to 3.164 x 
10-4 mol/L at 550 nm in the acid medium employed (Figure 
5). Hence, different concentrations of SMT were reacted with 
1 mL of 3.164 x 10-3 mol/L KMnO
4
 to determine the concen-
tration range over which SMT could be determined. One ml 
of 3.164 x 10-3 mol/L KMnO
4
 must be accurately added in 
all the reaction flasks since KMnO
4
 absorbs maximally at the 
analytical wavelength, and small changes in the volume of 
KMnO
4
 have a critical effect on the absorbance reading. The 
solvent used to dissolve SMT was 3:2 acetic acid, and below 
this concentration of acetic acid, SMT remained insoluble. 
The same acid concentration was used as a reaction medium. 
There was no effect of increasing the concentration of acetic 
acid on the reaction parameters. To check the effect of acid 
concentration on the reaction, 1-5 mL of 1 mol/L H
2
SO
4
 was 
added to the fixed concentration of SMT and KMnO
4
, and 
it was observed that there was absolutely no change in the 
absorbance. The effect of hydrochloric acid was not studied 
since KMnO
4
 being a strong oxidizing agent would react 
with HCl to liberate chlorine. The reaction between SMT and 
KMnO
4
 in acetic acid medium was complete in 10 min (Figu-
re 6), and the absorbance of the measured unreacted KMnO
4
 
was found to be stable up to 40 min thereafter. Two blanks 
were prepared for the study. The reagent blank consisted of 
acid and permanganate showed maximum absorbance (equal 
to the intercept). A second blank in the absence of SMT and 
KMnO
4
 had negligible absorbance, and hence measurements 
were made against a water blank.
Potassium permanganate quantitatively oxidizes 
SMT in the presence of NaOH in method B, resulting 
in the formation of a bluish-green color manganate ion 
(Mann and Sounders, 1974) which showed an absorption 
peak at 610 nm (Figure 7) and served as the basis for the 
calibration graph (Figure 3). Increase in the concentration 
of KMnO
4
 could enhance sensitivity of the method but the 
blank absorbance also increased concomitantly. The effect 
of KMnO
4
 concentration on the sensitivity of the reaction 
(Figure 8) was ascertained, and based on this the optimum 
concentration was fixed at 6.3278 x 10-4 mol/L. Order of 
addition of NaOH is critical. When NaOH was added after 
the addition of KMnO
4
 to SMT, small brown particles with 
slightly greenish turbidity developed, possibly due to the 
formation of MnO
2
 in weak alkaline medium. One mL of 
FIGURE 4 - Method A: Effect of SMT concentration on the 
absorbance of 3.164 x 10-4 mol/L KMnO
4
 (A.0.0; B.1.47; C.2.94; 
D.5.89; E.8.83; F.11.78; G.14.72 and H.17.67 x 10-5 mol/L SMT).
FIGURE 5 - Linear relation between absorbance at 550 nm and 
KMnO
4
 concentration.
FIGURE 6 - Effect of reaction time between KMnO
4
 and SMT 
in method A and method B.  
FIGURE 7 - Absorption spectra for method B. (Bluish green 
color produced for 27.18 x 10-6 mol/L SMT)
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0.5 mol/L NaOH in the total volume of 10 mL was fixed 
because there was no appreciable effect on the reaction 
time and sensitivity when the volume of 0.5 mol/L NaOH 
was varied from 0.5-2.0 mL. The reaction was complete 
in 20 min where the contact time was not critical and any 
delay up to 40 min had no effect on the absorbance. The 
absorbance of the measured color was constant for 50 
min in the presence of unreacted KMnO
4
 and the reaction 
product. In both the methods, the reaction rate was not 
studied at higher temperature since both the reactions 
reached completion within a reasonable time. The Job’s 
method of continuous variation was applied to establish 
the stoichiometric ratio of SMT to KMnO
4
 in basic medium 
and was found to be 1: 4 (SMT:KMnO
4
) (Figure 9).
Analytical data
A linear correlation was found between absorbance 
at l
max
 and concentration of SMT in the ranges given in 
Table I. This correlation establishes an inverse relation 
between SMT and permanganate. This behavior was pos-
sible because the latter follows the Beer-Lambert’s law. 
The inverse linear relationship in method A is described 
by the regression equation: 
Y = a - bX
(Where Y = absorbance of 1-cm layer of solution; a = 
FIGURE 8 - Effect of KMnO
4
 concentration for method B. 
FIGURE 9 - Job’s continuous variations plot.
TABLE I - Regression and Analytical parameters
Parameter Method A Method B
l
max
, nm 550 610
Range concentration limits, mol/L 1.47 – 17.67 x 10-5 2.27 – 27.18 x 10-6
Apparent molar absorptivity, L/ mol/ cm 3.2 x 103 2.5 x 104
Sandell sensitivity*, µg/cm2 0.0387 0.0178
Limit of detection, mol/L 3.13 x 10-6 1.29 x 10-6
Limit of quantification, mol/L 1.04 x 10-5 1.33 x 10-6
Regression equation, Y**
Intercept (a)
Slope (b)
0.6427
-0.0062
0.0209
0.0510
Correlation coefficient, (r) -0.9961 0.9987
S
a
0.01601 0.01130
S
b
0.00025 0.00112
*Is a sensitivity parameter in µg/cm2 SMT corresponding to an absorbance of 0.001 measured in a cuvette of cross-sectional area 
1 cm2 and L= 1cm.
Y** = a ± bX, where Y is the absorbance and X concentration in mol/L; S
a
= Standard deviation of intercept; S
b
= Standard deviation 
of slope.
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intercept; b = slope and X = concentration in mol/L). 
Regression analysis of the linear relation data using the 
method of least squares was performed to evaluate the 
slope (b), intercept (a) and correlation coefficient (r) for 
each system, and the values are presented in Table I. 
The optical characteristics such as range concentration 
limits, apparent molar absorptivity and Sandell sensi-
tivity values of both methods are also given in Table I. 
The limits of detection (LOD) and quantification (LOQ) 
calculated according to ICH guidelines (1996) are also 
presented in Table I.
Method Validation
Assay precision and accuracy
The precision of the methods was calculated in 
terms of intermediate precision (intra-day and inter-day) 
(SHABIR, G.A, 2003). Three different concentrations of 
SMT were analyzed in seven replicates during the same 
day (intra-day precision) and for five consecutive days 
(inter-day precision). The RSD (%) values of intra-day 
and inter-day studies showed that the precision was 
good (Table III). The accuracy of an analytical method 
expresses the closeness between the reference value and 
the found value. Accuracy was evaluated as percentage 
relative error between the measured concentrations and 
concentrations taken for SMT (Bias %). The results obtai-
ned are compiled in Table II and show that the accuracy 
is good. 
Method Selectivity
Selectivity was evaluated by recovery studies. A 
synthetic mixture consisting of 20 mg sodium alginate, 
30 mg magnesium stearate, 20 mg lactose, 20 mg acacia, 
50 mg talc and 30 mg starch besides 20 mg of SMT was 
prepared and analyzed after extraction into acetic acid in 
method A, and into chloroform in the case of method B, as 
described under analysis of tablets. The percent recovery 
of SMT was 98.64 ± 0.86 and 96.58 ± 0.63 for method A 
and method B, respectively. This confirms the selectivity 
of methods under the optimized conditions.
Placebo analysis
Placebo analysis was carried out in order to find the 
interference. A placebo blank consisting of 20 mg sodium 
alginate, 30 mg magnesium stearate, 20 mg lactose, 20 mg 
acacia, 50 mg talc and 30 mg starch but without SMT was 
prepared and analyzed as described under “procedure for 
tablets”. There was absolutely no interference from the 
placebo in method A but huge interference was encounte-
red in method B. The interference from placebo mixture 
in method B was successfully overcome by extraction of 
SMT into chloroform and by performing the analysis as 
described under tablets.
Application to analysis of pharmaceutical formulations
Method A does not suffer from interference from 
the tablet excipients and results in Table III show close 
agreement between the results obtained by the proposed 
methods and the label claim. Method B entails extraction 
of SMT into chloroform since there was some interference 
from the excipients when applied directly to the tablet 
extract in NaOH. The chloroform was later evaporated 
and residue was dissolved in NaOH where an appropriate 
working concentration of SMT was prepared and analyzed 
as given under assay procedure for tablets. The results 
were compared statistically by applying Student’s t-test for 
accuracy and the variance ratio F-test for precision with 
results from the literature method (Arayne et al., 2007) at 
a 95% confidence level. The calculated t-test and F-values 
(Table III) did not exceed the tabulated values of 2.37 and 
6.39, respectively, indicating no significant difference 
TABLE II - Intra-day and Inter-day precision and accuracy evaluation
Method SMT 
( x 10-5 
mol/L) 
taken 
Intra-day (n=7) Inter-day (n=5)
SMT 
( x 10-5 mol/L) 
founda
Precisionb Accuracyc SMT 
( x 10-5 mol/L) 
founda
Precisionb Accuracyc
A
B
2.94 2.98 1.15 1.56 2.99 1.85 1.72
8.83 8.99 1.82 0.97 8.96 1.51 1.34
14.72 14.95 1.57 0.58 15.00 1.95 0.98
0.45 0.46 2.00 1.83 0.47 1.00 2.15
1.36 1.37 0.83 1.26 1.37 1.58 1.58
2.26 2.28 0.90 0.72 2.28 0.70 0.84
a. Mean ± Mean value of n determinations, b. Relative standard deviation (%), c. Bias %: .
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between the proposed methods and the reference method 
in terms of accuracy and precision. The validity of the 
methods was confirmed by applying the standard addition 
technique. Pre-analyzed tablet powder containing SMT 
was spiked with pure SMT at three concentration levels 
and the totals were found by the proposed methods. Each 
determination was done three times. The results of this 
study are compiled in Table IV.
CONCLUSIONS
Two simple, rapid, fairly accurate and precise, and 
sensitive spectrophotometric methods were developed for 
the determination of SMT in bulk drug and in tablets. The 
methods are free from rigid experimental conditions and 
are characterized by wide linear dynamic ranges and high 
sensitivity, and employ inexpensive and easily available 
chemicals. The low detection and quantification limits, 
simplicity and selectivity make the method suitable for 
quality control in the pharmaceutical industry for routine 
analysis. However, method B entails an extraction step 
when applied to tablets to overcome the interference from 
some inactive ingredients.
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TABLE IV - Results of recovery study by standard addition method
Formulation   
studied
Method A Method B
SMT in 
tablet 
(x 10-5 
mol/L) 
Pure SMT 
added, 
( x 10-5 
mol/L)
Total 
found, 
(x 10-5 
mol/L)
Pure SMT 
recovered*, 
Percent ± SD
SMT in   
tablet, 
(x 10-6 
mol/L)
Pure SMT 
added, 
(x 10-6 
mol/L)
Total 
found, (x 
10-6 mol/L)
Pure SMT 
recovered*, 
Percent ± SD
Zosta, 
20 mg
6.86 3.39 10.30 101.40 ± 1.28 9.04 4.53 13.52 99.00 ± 0.76
6.86 6.79 13.90 103.70 ± 1.76 9.04 9.06 17.85 97.25 ± 1.04
6.86 10.19 17.12 100.70 ± 1.12 9.04 13.59 22.04 95.67 ± 0.85
Simvofix,
40 mg
7.00 3.39 10.57 103.20 ± 0.85 9.22 4.53 13.77 100.50 ± 0.64
7.00 6.79 14.02 103.30 ± 0.74 9.22 9.06 18.59 103.50 ± 1.02
7.00 10.19 17.35 101.40 ± 1.20 9.22 13.59 22.97 101.20 ± 0.86
*Mean value of three determinations
TABLE III - Results of assay of tablets and statistical evaluation
                        
Tablet brand 
name**
Nominal amount 
mg
Found (% of nominal amount ± SD)*
Literature method*** Method A  Method B
Simvofixa 20 99.64 ± 0.78 98.85 ± 1.26
t = 1.22
F = 2.60
100.14 ± 0.74
t = 1.04
F = 1.11
40 102.50 ± 0.62 103.10 ± 0.96
t = 1.20
F = 2.40
101.80 ± 0.36
t = 2.26
F = 2.97
Zostab 10 97.62 ± 0.86 98.74 ± 1.65
t = 1.41
F = 3.68
96.83 ± 1.11
t =1.48 
F = 1.67
20 100.30 ± 0.58 101.00 ± 1.42
t = 1.10
F = 5.99
99.78 ± 1.26
t = 0.89
F = 4.72
*Mean value of five determinations. **Marketed by: a. Bal Pharma (Servetus); b. USV (Corvette). Tabulated t-value at the 95% 
confidence level is 2.77; Tabulated F-value at the 95% confidence level is 6.39. ***Arayne et al. 2007
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